Valneva‘s Chikungunya Vaccine Faces EMA Review Over Adverse Effects Table of Contents Valneva’s Chikungunya Vaccine Faces EMA Review Over Adverse Effects Limited Use, Adverse Reactions Trigger Review Vaccine Use Suspended for Those Over 65 EMA Cites ‘Uncertain’ Link,Highlights Contraindications Valneva Reaffirms Commitment to Safety Valneva’s Chikungunya Vaccine: Answering Your Questions what is the IXCHIQ vaccine? […]
The post Valneva: EMA Leans on IXCHIQ After Serious Cases appeared first on News Directory 3.